关注
CHAE YOUNG Han
CHAE YOUNG Han
Postdoctoral fellow, MD Anderson Cancer Research Center
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer
H Alam, M Tang, M Maitituoheti, SS Dhar, M Kumar, CY Han, CR Ambati, ...
Cancer cell 37 (4), 599-617. e7, 2020
1832020
Hexokinase 2 regulates ovarian cancer cell migration, invasion and stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 signaling cascades
MKY Siu, YX Jiang, JJ Wang, THY Leung, CY Han, BK Tsang, ...
Cancers 11 (6), 813, 2019
1102019
Biomarkers and strategies for early detection of ovarian cancer
RC Bast Jr, Z Lu, CY Han, KH Lu, KS Anderson, CW Drescher, SJ Skates
Cancer Epidemiology, Biomarkers & Prevention 29 (12), 2504-2512, 2020
892020
p53 sensitizes chemoresistant non-small cell lung cancer via elevation of reactive oxygen species and suppression of EGFR/PI3K/AKT signaling
Y Zhang, CY Han, FG Duan, XX Fan, XJ Yao, RJ Parks, YJ Tang, ...
Cancer cell international 19, 1-13, 2019
642019
Tumor metabolism regulating chemosensitivity in ovarian cancer
CY Han, DA Patten, RB Richardson, ME Harper, BK Tsang
Genes & cancer 9 (5-6), 155, 2018
592018
Cellular adaptation to anthrax lethal toxin-induced mitochondrial cholesterol enrichment, hyperpolarization, and reactive oxygen species generation through downregulating MLN64 …
SD Ha, S Park, CY Han, ML Nguyen, SO Kim
Molecular and Cellular Biology, 2012
392012
HDAC8-Mediated Epigenetic Reprogramming Plays a Key Role in Resistance to Anthrax Lethal Toxin–Induced Pyroptosis in Macrophages
SD Ha, CY Han, C Reid, SO Kim
The Journal of Immunology 193 (3), 1333-1343, 2014
362014
p53 Promotes chemoresponsiveness by regulating hexokinase II gene transcription and metabolic reprogramming in epithelial ovarian cancer
CY Han, DA Patten, SG Lee, RJ Parks, DW Chan, ME Harper, BK Tsang
Molecular Carcinogenesis 58 (11), 2161-2174, 2019
332019
Ring finger protein 6 mediates androgen-induced granulosa cell proliferation and follicle growth via modulation of androgen receptor signaling
JJ Lim, CY Han, DR Lee, BK Tsang
Endocrinology 158 (4), 993-1004, 2017
332017
Next steps in the early detection of ovarian cancer
RC Bast, CY Han, Z Lu, KH Lu
Communications medicine 1 (1), 36, 2021
252021
Nuclear HKII-P-p53 (Ser15) interaction is a prognostic biomarker for Chemoresponsiveness and glycolytic regulation in epithelial ovarian Cancer
CY Han, DA Patten, SI Kim, JJ Lim, DW Chan, MKY Siu, Y Han, ...
Cancers 13 (14), 3399, 2021
102021
A blood-based metabolite panel for distinguishing ovarian cancer from benign pelvic masses
E Irajizad, CY Han, J Celestino, R Wu, E Murage, R Spencer, ...
Clinical Cancer Research 28 (21), 4669-4676, 2022
92022
Normal Risk Ovarian Screening Study: 21-Year Update
CY Han, KH Lu, G Corrigan, A Perez, SD Kohring, J Celestino, D Bedi, ...
Journal of Clinical Oncology 42 (10), 1102-1109, 2024
62024
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer
C Young Han, JS Bedia, WL Yang, SJ Hawley, L Bergan, M Hopper, ...
British journal of cancer 130 (5), 861-868, 2024
62024
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers
B Kong, CY Han, SI Kim, DA Patten, Y Han, E Carmona, DB Shieh, ...
Journal of Ovarian Research 15 (1), 70, 2022
62022
The Normal Risk Ovarian Screening Study (NROSS): Twenty-one year update.
CY Han, KH Lu, D Bedi, E Bedia, TB Bevers, LL Holman, L Leeds, ...
Journal of Clinical Oncology 41 (16_suppl), 5522-5522, 2023
12023
Correction: Siu et al. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades. Cancers 2019, 11, 813
MKY Siu, YX Jiang, JJ Wang, THY Leung, CY Han, BK Tsang, ...
Cancers 16 (21), 3633, 2024
2024
A metabolite-based liquid biopsy for detection of ovarian cancer
JF Fahrmann, SM Ghasemi, CY Han, R Wu, JB Dennison, J Vykoukal, ...
Biomarker Research 12 (1), 91, 2024
2024
Phb1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers
B Kong, CY Han, SI Kim, DA Patten, Y Han, E Carmona, DB Shieh, ...
2022
The Role of Hexokinase II in the Regulation of Glycolysis and Cisplatin Sensitivity in Ovarian Cancer
CY Han
Université d'Ottawa/University of Ottawa, 2018
2018
系统目前无法执行此操作,请稍后再试。
文章 1–20